1. |
郑荣寿, 孙可欣, 张思维, 等. 2015 年中国恶性肿瘤流行情况分析. 中华肿瘤杂志, 2019, 41(1): 19-28.
|
2. |
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
|
3. |
Sawabata N, Ohta M, Matsumura A, et al. Optimal distance of malignant negative margin in excision of nonsmall cell lung cancer: A multicenter prospective study. Ann Thorac Surg, 2004, 77(2): 415-420.
|
4. |
Jensik RJ, Faber LP, Milloy FJ, et al. Segmental resection for lung cancer. A fifteen-year experience. J Thorac Cardiovasc Surg, 1973, 66(4): 563-572.
|
5. |
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 1995, 60(3): 615-622.
|
6. |
Khullar OV, Liu Y, Gillespie T, et al. Survival after sublobar resection versus lobectomy for clinical stage ⅠA lung cancer: An analysis from the National Cancer Data Base. J Thorac Oncol, 2015, 10(11): 1625-1633.
|
7. |
Dai C, Shen J, Ren Y, et al. Choice of surgical procedure for patients with non-small-cell lung cancer ≤1 cm or > 1 to 2 cm among lobectomy, segmentectomy, and wedge resection: A population-based study. J Clin Oncol, 2016, 34(26): 3175-3182.
|
8. |
Onaitis MW, Furnary AP, Kosinski AS, et al. Equivalent survival between lobectomy and segmentectomy for clinical stage ⅠA lung cancer. Ann Thorac Surg, 2020, 110(6): 1882-1891.
|
9. |
Kamigaichi A, Tsutani Y, Kagimoto A, et al. Comparing segmentectomy and lobectomy for clinical stage ⅠA solid-dominant lung cancer measuring 2. 1 to 3 cm. Clin Lung Cancer, 2020, 21(6): e528-e538.
|
10. |
Ijsseldijk MA, Shoni M, Siegert C, et al. Oncological outcomes of lobar resection, segmentectomy, and wedge resection for T1a non-small-cell lung carcinoma: A systematic review and meta-analysis. Semin Thorac Cardiovasc Surg, 2020, 32(3): 582-590.
|
11. |
Nomori H, Shiraishi A, Yamazaki I, et al. Extent of segmentectomy that achieves greater lung preservation than lobectomy. Ann Thorac Surg, 2020, 20: S0003-4975(20)31930-5.
|
12. |
Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: Post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med, 2018, 6(12): 915-924.
|
13. |
Suzuki K, Saji H, Aokage K, et al. Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial. J Thorac Cardiovasc Surg, 2019, 158(3): 895-907.
|
14. |
Roman M, Labbouz S, Valtzoglou V, et al. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes. Eur J Surg Oncol, 2019, 45(5): 845-850.
|
15. |
Handa Y, Tsutani Y, Mimae T, et al. Surgical procedure selection for stageⅠ lung cancer: Complex segmentectomy versus wedge resection. Clin Lung Cancer, 2021, 22(2): e224-e233.
|
16. |
Suzuki K, Watanabe SI, Wakabayashi M, et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg, 2020, 12: S0022-5223(20)33043-9.
|
17. |
Suzuki K, Koike T, Asakawa T, et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical ⅠA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol, 2011, 6(4): 751-756.
|
18. |
Nakamura K, Saji H, Nakajima R, et al. A phase Ⅲ randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol, 2010, 40(3): 271-274.
|
19. |
Aokage K, Saji H, Suzuki K, et al. A non-randomized confirmatory trial of segmentectomy for clinical T1N0 lung cancer with dominant ground glass opacity based on thin-section computed tomography (JCOG1211). Gen Thorac Cardiovasc Surg, 2017, 65(5): 267-272.
|
20. |
Raman V, Jawitz OK, Voigt SL, et al. The effect of tumor size and histologic findings on outcomes after segmentectomy vs. lobectomy for clinically node-negative non-small cell lung cancer. Chest, 2021, 159(1): 390-400.
|
21. |
Kamigaichi A, Tsutani Y, Fujiwara M, et al. Postoperative recurrence and survival after segmentectomy for clinical stage 0 or ⅠA lung cancer. Clin Lung Cancer, 2019, 20(5): 397-403.
|
22. |
Nishio W, Yoshimura M, Maniwa Y, et al. Re-assessment of intentional extended segmentectomy for clinical T1aN0 non-small cell lung cancer. Ann Thorac Surg, 2016, 102(5): 1702-1710.
|
23. |
Lin CY, Chang CC, Liu YS, et al. Stapled video-assisted thoracoscopic segmentectomy preserves as much lung volume as nonstapled video-assisted thoracoscopic segmentectomy. Asian J Surg, 2021, 44(1): 131-136.
|
24. |
Wang W, Hu Z, Zhao J, et al. Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: A meta-analysis. J Cardiothorac Surg, 2020, 15(1): 154.
|
25. |
Tsutani Y, Suzuki K, Koike T, et al. High-risk factors for recurrence of stageⅠlung adenocarcinoma: Follow-up data from JCOG0201. Ann Thorac Surg, 2019, 108(5): 1484-1490.
|
26. |
Eguchi T, Kameda K, Lu S, et al. Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: A propensity score-matched analysis. J Thorac Oncol, 2019, 14(1): 87-98.
|
27. |
北京医学会胸外科分会, 中国医疗保健国际交流促进会胸外科分会. 基于高分辨 CT 影像学指导≤2 cm 磨玻璃结节肺癌手术方式胸外科专家共识(2019 版). 中国胸心血管外科临床杂志, 2020, 27(4): 395-400.
|
28. |
Qian F, Yang W, Wang R, et al. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stageⅠB lung adenocarcinoma. J Thorac Cardiovasc Surg, 2018, 155(3): 1227-1235.
|
29. |
Liu H, Yin Q, Yang G, et al. Prognostic impact of tumor spread through air spaces in non-small cell lung cancers: A meta-analysis including 3564 patients. Pathol Oncol Res, 2019, 25(4): 1303-1310.
|
30. |
Kadota K, Kushida Y, Kagawa S, et al. Limited resection is associated with a higher risk of locoregional recurrence than lobectomy in stageⅠlung adenocarcinoma with tumor spread through air spaces. Am J Surg Pathol, 2019, 43(8): 1033-1041.
|
31. |
Zhang Z, Liu Z, Feng H, et al. Predictive value of radiological features on spread through air space in stage cⅠA lung adenocarcinoma. J Thorac Dis, 2020, 12(11): 6494-6504.
|
32. |
Chen D, Wang X, Zhang F, et al. Could tumor spread through air spaces benefit from adjuvant chemotherapy in stageⅠlung adenocarcinoma? A multi-institutional study. Ther Adv Med Oncol, 2020, 12: 1758835920978147.
|
33. |
Nomori H, Mori T, Shiraishi A, et al. Long-term prognosis after segmentectomy for cT1N0M0 non-small cell lung cancer. Ann Thorac Surg, 2019, 107(5): 1500-1506.
|